/PRNewswire/ Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022 s.
Even in a year that saw new drugs for Alzheimer's disease and cancer greenlighted for use in the United States, treatments for weight loss garnered a bulk of health-related headlines in 2023.
Weight-loss medications captured Americans attention in 2023 kansas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kansas.com Daily Mail and Mail on Sunday newspapers.